Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial
暂无分享,去创建一个
W. Rottbauer | V. Hombach | J. Wöhrle | H. Schrezenmeier | P. Bernhardt | S. Markovic | M. Wiesneth | P. Schauwecker | Fabian von Scheidt
[1] S. Fisher,et al. Stem cell treatment for acute myocardial infarction. , 2015, The Cochrane database of systematic reviews.
[2] E. Marbán,et al. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction , 2012, Journal of cellular and molecular medicine.
[3] W. Rottbauer,et al. CORONARY ARTERY DISEASE Original Studies Effect of Bivalirudin Compared With Unfractionated Heparin Plus Abciximab on Infarct Size and Myocardial Recovery After Primary Percutaneous Coronary Intervention: The HORIZONS-AMI CMRI Substudy , 2012 .
[4] A. Quyyumi,et al. Intracoronary bone marrow mononuclear cells after myocardial infarction. , 2012, JAMA.
[5] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[6] S. Ellis,et al. Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study , 2012, Circulation research.
[7] H. Krum,et al. Short‐ and long‐term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST‐segment elevation myocardial infarction: a meta‐analysis of randomized control trials , 2012, European journal of heart failure.
[8] S. Fisher,et al. Stem cell treatment for acute myocardial infarction. , 2012, The Cochrane database of systematic reviews.
[9] Doris A Taylor,et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.
[10] B. Strauer,et al. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.
[11] K. Schwarz,et al. Results of intracoronary stem cell therapy after acute myocardial infarction. , 2010, American Journal of Cardiology.
[12] H. Kestler,et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy , 2009, European heart journal.
[13] S. Brunskill,et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. , 2008, European heart journal.
[14] L. Dušek,et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. , 2006, American heart journal.
[15] H. Kestler,et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. , 2005, European heart journal.
[16] H. Majima. [Phase I clinical study]. , 1984, Gan to kagaku ryoho. Cancer & chemotherapy.